Quantitative Evaluation of Research Integrity Policies in Medical Field Based on Policy Modeling Consistency Index Model.

内容摘要

Objective To quantitatively evaluate China's core research integrity policies by constructing an evaluation index system specific to the medical field and reveal the applicability and structural shortcomings of these policies,thereby providing empirical evidence and optimization pathways for enhancing the scientific rigor and practical effectiveness of research integrity governance in China. Methods Eighteen research integrity policy documents issued at the national level by the central government and ministries from January 2010 to January 2025 were collected.An evaluation framework based on the policy modeling consistency index model was constructed via text mining and keyword analysis to quantitatively assess the consistency and effectiveness of these policies.According to their scores,the policies were rated as excellent,good,medium,or bad grade. Results The 18 policies showed the average policy modeling consistency index of 6.27 and the sag index of 2.73,which indicated good overall performance but with clear disparities.Among them,3 policies were rated as excellent,6 as good,and 9 as medium.Analysis of the dimensional averages revealed that while the policies performed robustly in terms of policy function and policy timeliness,they exhibited significant shortcomings in the dimensions of policy target and policy scope,with average scores of 0.59 and 0.44,respectively. Conclusions While China's medical research integrity policy framework is generally effective,it exhibits clear structural shortcomings,including a lack of international perspective,monolithic policy targets,insufficient enforcement rigidity,and low operability.Accordingly,it is recommended that measures such as aligning with global standards,establishing a multi-stakeholder collaborative governance network,strengthening policy enforcement,and improving policy operability should be adopted.These measures will help to systematically optimize China's medical research integrity policy system,thereby enhancing the overall governance level in this domain. 目的 通过构建医学领域科研诚信政策评价指标体系,对我国主要科研诚信政策进行量化评估,旨在揭示科研诚信政策在医学领域的适用性水平与结构性短板,从而为提升我国医学领域科研诚信治理的科学性与实践效能提供实证依据与优化路径。方法 收集2010年1月至2025年1月国家及部委层面发布的18项科研诚信政策文件,通过文本挖掘和关键词分析构建基于政策一致性指数模型的评价指标体系,量化评估政策的一致性与有效性,并依据得分范围将政策分为优秀、良好、中等、不良4个等级。结果 18项政策一致性指数均值为6.27,整体呈现良好水平,凹陷指数均值为2.73,但存在明显参差,其中优秀级3项、良好级6项、中等级9项。从各维度均值看,政策功能与政策时效维度表现稳固,但在政策客体与政策作用范围维度上存在显著不足,其均值分别为0.59和0.44。结论 我国医学领域科研诚信政策整体表现良好,但存在缺乏国际化视野、政策客体单一、政策执行刚性和实操性不足等短板,建议采取与全球标准对接、构建多元主体协同治理网络、增强政策执行刚性、提升内容可操作性等措施,系统性地优化我国医学领域科研诚信政策体系,以整体提升我国医学领域科研诚信治理水平。.